NY S08040 | 2023-2024 | General Assembly
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 5 2024 - 25% progression
Action: 2024-01-29 - SUBSTITUTED BY A8502
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 5 2024 - 25% progression
Action: 2024-01-29 - SUBSTITUTED BY A8502
Text: Latest bill text (Introduced) [HTML]
Summary
Requires health insurance policies and medicaid to cover biomarker precision medical testing for diagnosis, treatment, or appropriate management of, or ongoing monitoring to guide treatment decisions for, a covered person's disease or condition when the test has recognized efficacy and appropriateness for such purposes.
Title
Requires health insurance policies and medicaid to cover biomarker precision medical testing for diagnosis, treatment, or appropriate management of, or ongoing monitoring to guide treatment decisions for, a covered person's disease or condition when the test has recognized efficacy and appropriateness for such purposes.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-01-29 | Senate | SUBSTITUTED BY A8502 |
| 2024-01-08 | Senate | ORDERED TO THIRD READING CAL.40 |
| 2024-01-05 | Senate | REFERRED TO RULES |
Same As/Similar To
A08502 (Same As) 2024-02-07 - signed chap.29
